Compare Uniphos Enter. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.83
- The company has reported losses. Due to this company has reported negative ROCE
Flat results in Dec 25
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Aug-29-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Uniphos Enterprises Ltd Falls to 52-Week Low of Rs 87.35 as Sell-Off Deepens
For the second consecutive session, Uniphos Enterprises Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 87.35 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector and benchmark indices.
Read full news article
Uniphos Enterprises Ltd Falls to 52-Week Low Amidst Continued Financial Struggles
Shares of Uniphos Enterprises Ltd have declined to a fresh 52-week low, reflecting ongoing challenges in the company’s financial performance and market positioning. The stock’s latest low price underscores a year-long trend of underperformance relative to broader market indices and sector peers.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Feb-2026 | Source : BSEPlease find attached copy of newspaper publication of an extract of Unaudited Financial Results for the quarter and nine months ended 31st December 2025.
Board Meeting Outcome for UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2025
06-Feb-2026 | Source : BSEPlease find attached Unaudited Financial Results for the quarter and nine months ended 31st December 2025.
UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2025
06-Feb-2026 | Source : BSEPlease find attached Unaudited Financial Results for the quarter and nine months ended 31st December 2025
Corporate Actions 
No Upcoming Board Meetings
Uniphos Enterprises Ltd has declared 25% dividend, ex-date: 29 Aug 25
No Splits history available
No Bonus history available
Uniphos Enterprises Ltd has announced 173:100 rights issue, ex-date: 18 Sep 13
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 3 Schemes (0.0%)
Held by 14 FIIs (15.71%)
Nerka Chemicals Pvt Ltd (73.28%)
Ares Diversified (4.56%)
8.94%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -104.36% vs 3,229.73% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -82.51% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 504.31% vs -90.55% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -84.82% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,057.30% vs -95.29% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 120.16% vs 3,345.58% in Mar 2024
YoY Growth in year ended Mar 2025 is -99.27% vs -1.58% in Mar 2024







